Drugmakers raise 2018 U.S. prices, stick to self-imposed limits
Source: Reuters
JANUARY 2, 2018 / 5:35 PM / UPDATED 40 MINUTES AGO
Michael Erman
NEW YORK (Reuters) - Drugmakers opened the new year by raising U.S. prices on dozens of medicines, but early data showed the increases generally remained within a 10 percent self-imposed limit in response to a backlash from consumers and politicians.
Soaring U.S. prices for both branded and generic drugs have sparked public outrage and government investigations over the past few years. “Drug price increases are somewhat more constrained in 2017 and 2018 than they have been previously,” Cowen and Co analyst Eric Schmidt said.
Allergan Inc (AGN.N) raised prices on 18 different drugs, including dry eye treatment Restasis and irritable bowel syndrome drug Linzess, by 9.5 percent, according to a research note released by Jefferies on Tuesday.
Jefferies cited data collected by Medi-Span Price Rx and refers to list price increases, before potentially significant discounts and rebates that drugmakers provide to win preferred coverage by insurers. Medi-Span did not respond to requests to confirm the data.
Read more: https://www.reuters.com/article/us-usa-healthcare/drugmakers-raise-2018-u-s-prices-stick-to-self-imposed-limits-idUSKBN1ER1UL
= new reply since forum marked as read
I did pay for my health care out of my paycheck to cover my health care costs and drug costs, that ate into my paycheck, of around $500 a dollars a month
